Journey Medical Corporation (NASDAQ: DERM) Stock Information | RedChip

Journey Medical Corporation (NASDAQ: DERM)


$5.5400
+0.3400 ( +7.16% ) 68.4K

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Market Data


Open


$5.5400

Previous close


$5.2000

Volume


68.4K

Market cap


$113.85M

Day range


$4.9400 - $5.6100

52 week range


$2.8500 - $8.1100

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 Nov 12, 2024
10-q Quarterly Reports 91 Nov 12, 2024
8-k 8K-related 15 Nov 04, 2024
10-q Quarterly Reports 87 Aug 13, 2024
8-k 8K-related 15 Aug 12, 2024
4 Insider transactions 1 Aug 01, 2024
4 Insider transactions 1 Jul 23, 2024
4 Insider transactions 1 Jul 23, 2024
3 Insider transactions 2 Jul 19, 2024
8-k 8K-related 13 Jul 12, 2024

Latest News